234 related articles for article (PubMed ID: 1961034)
1. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
Mills KI; Sproul AM; Leibowitz D; Burnett AK
Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
Mills KI; Sproul AM; Burnett AK
Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.
Iwata S; Mizutani S; Nakazawa S; Yata J
Leukemia; 1994 Oct; 8(10):1696-702. PubMed ID: 7934165
[TBL] [Abstract][Full Text] [Related]
4. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
5. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
Inokuchi K; Nomura T
Leuk Lymphoma; 1993 May; 10(1-2):9-15. PubMed ID: 8374529
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
8. Amplification and sequencing of genomic breakpoints located within the M-bcr region by Vectorette-mediated polymerase chain reaction.
Mills KI; Sproul AM; Ogilvie D; Elvin P; Leibowitz D; Burnett AK
Leukemia; 1992 May; 6(5):481-3. PubMed ID: 1317490
[TBL] [Abstract][Full Text] [Related]
9. Molecular studies of chronic myelogenous leukemia using the polymerase chain reaction.
Nakamura K; Miyashita T; Ozaki M; Iwaya M; Nakazawa S; Okamura J; Kamada N; Tanaka K; Kobayashi N; Mizutani S
Cancer; 1991 Dec; 68(11):2426-30. PubMed ID: 1933779
[TBL] [Abstract][Full Text] [Related]
10. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.
Inokuchi K; Inoue T; Tojo A; Futaki M; Miyake K; Yamada T; Tanabe Y; Ohki I; Dan K; Ozawa K
Blood; 1991 Dec; 78(12):3125-7. PubMed ID: 1742479
[TBL] [Abstract][Full Text] [Related]
11. Molecular abnormalities of bcr gene in some Indian patients with chronic myeloid leukaemia.
Chandrasekaran R; Murthy PB
Indian J Med Res; 1996 May; 103():267-71. PubMed ID: 8707363
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
13. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
15. Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within BCR exons.
How GF; Lim LC; Kulkarni S; Tan LT; Tan P; Cross NC
Br J Haematol; 1999 May; 105(2):434-6. PubMed ID: 10233416
[TBL] [Abstract][Full Text] [Related]
16. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
17. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
[TBL] [Abstract][Full Text] [Related]
18. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; PastwiĆska A; Konopka L; Majewski M
Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
[TBL] [Abstract][Full Text] [Related]
19. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
Melo JV; Goldman JM
Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
[TBL] [Abstract][Full Text] [Related]
20. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]